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ABSTRACT
Estrella lausannensis is a new member of the Chlamydiales order. Like other Chlamydia-related bacteria, it is able to replicate in
amoebae and in fish cell lines. A preliminary study investigating the pathogenic potential of Chlamydia-related bacteria
found a correlation between antibody response to E. lausannensis and pneumonia in children. To further investigate the
pathogenic potential of E. lausannensis, we determined its ability to grow in human macrophages and its intracellular
trafficking. The replication in macrophages resulted in viable E. lausannensis; however, it caused a significant cytopathic
effect. The intracellular trafficking of E. lausannensis was analyzed by determining the interaction of the Estrella-containing
inclusions with various endocytic markers as well as host organelles. The E. lausannensis inclusion escaped the endocytic
pathway rapidly avoiding maturation into phagolysosomes by preventing both EEA-1 and LAMP-1 accumulation. Compared
to Waddlia chondrophila, another Chlamydia-related bacteria, the recruitment of mitochondria and endoplasmic reticulum
was minimal for E. lausannensis inclusions. Estrella lausannensis appears to use a distinct source of nutrients and energy
compared to other members of the Chlamydiales order. In conclusion, we hypothesize that E. lausannensis has a restricted
growth in human macrophages, due to its reduced capacity to control programmed cell death.
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INTRODUCTION
Estrella lausannensis is a new member of the Chlamydiales order
(Lienard et al. 2011b), isolated from a Spanish river sample by
amoebal coculture (Corsaro et al. 2009). With Criblamydia sequa-
nensis that was also recovered by amoebal co-culture from the
Seine river in Paris (Thomas, Casson and Greub 2006), E. lausan-
nensis is one of the two species assigned to the Criblamydiaceae
family (Thomas, Casson and Greub 2006; Lienard et al. 2011b).
The number of members in the Chlamydiales order has been
constantly growing in recent years (Everett, Bush and Andersen
1999; Greub 2010). Environmental samples and metagenomics
projects have provided a tremendous source of new members
and families within the Chlamydiales order, showing the high
biodiversity and widespread occurrence of this clade of strict
intracellular bacteria (Lienard et al. 2011b; Pizzetti et al. 2012;
Lagkouvardos et al. 2013). However, the majority of the studies
only offered information at the phylogenetic level without iso-
lation and functional studies. Initial studieswith a fewmembers
of other families besides the Chlamydiaceae have already shown
that the replication strategies of these obligate intracellular bac-
teria can be diverse and may reflect their adaptation to specific
hosts (Kebbi-Beghdadi, Bertelli and Greub 2012).
Criblamydiaceae exhibit the same replication cycle with in-
fectious elementary bodies (EBs) and replicative reticulate bod-
ies (RBs) as other members of the Chlamydiales order (Lienard
et al. 2011b). Chlamydiales reside throughout the infection within
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a vacuole called inclusion. The nature of the inclusion and the
organelles that interact with it varies between members of the
Chlamydiales order (Kebbi-Beghdadi, Bertelli and Greub 2012). For
example, Chlamydia trachomatis inclusions associate with Golgi
fragments (Hackstadt, Scidmore and Rockey 1995),Waddlia chon-
drophilawith the endoplasmic reticulum (ER; Croxatto andGreub
2010), whereas Parachlamydia acanthamoebae remains in the en-
docytic pathway, but prevents the acidification of the inclusion
and the acquisition of lysosomal hydrolases, such as cathepsin
(Greub et al. 2005). For many other members of the Chlamydiales
order, the trafficking in the host cell remains unknown.
Upon an initial report on the growth of E. lausannensis in
several amoebal hosts (Lienard et al. 2011b), Kebbi-Beghdadi,
Batista and Greub (2011) showed that E. lausannensis also repli-
cates within fish cell lines, and in preliminary studies in en-
dometrial cells and pneumocytes. The wide range of cell types
that could be infected by E. lausannensis suggests a wider
host range than Chlamydiaceae. Interestingly, it was shown
that its growth rate within amoebae is increasing at higher
temperatures (Lienard et al. 2011b). Moreover, the presence of
E. lausannensis or a related Criblamydiaceae in human samples
was shown in a study on nasopharyngeal swabs from children
with pneumonia (Lienard et al. 2011a). These observations sug-
gested that E. lausannensis could also replicate within phago-
cytic cells, such as human macrophages and could represent an
emerging pathogen. Recently, the genome of E. lausannensis be-
came publicly accessible andwill provide an important source of
information to investigate virulence factors (Bertelli et al. 2015).
We therefore decided to investigate the replication of
E. lausannensis in human macrophages, since they are the first
response innate immune cells in the lung. We could demon-
strate that macrophages are permissive to E. lausannensis and
therefore further investigated its intracellular trafficking.
MATERIAL AND METHODS
Cell differentiation and bacterial strains
The human cell line PLB-985 was kindly provided by M. Grez
(Frankfurt, Germany). Cells were cultured in RPMI (Gibco-BRL
Life Technologies, Basel, Switzerland), 10% FCS (Biochrom,
Berlin, Germany) at 37◦C with 5% CO2. To differentiate mono-
cytes into macrophages, cells were exposed to 50 nM PMA for
48 h. The Chlamydia-related bacteria E. lausannensis (CRIB30) and
W. chondrophila (ATCC VR-1470) were cultivated in Acanthamoeba
castellanii (ATCC30010) as previously described (Bertelli et al.
2010).
DNA extraction and qPCR
Genomic DNA of W. chondrophila and E. lausannensis was ex-
tracted using the tissue extraction protocol from Wizard SV Ge-
nomic DNA kit (Promega, MA, USA). Samples were quantified by
qPCR as published before (Goy et al. 2009; Lienard et al. 2011a).
Infectivity
Macrophages infected with E. lausannensis were collected at 0
and 24 h p.i. with the supernatant. The samples were mixed
with glass beads to disrupt the cells and filtered on 5 μm filters
to remove debris and serially diluted. The serial dilutions were
used to infect Vero cells by spinoculation. The infected cellswere
fixed after 24 h and inclusions containing E. lausannensis were
stained with in-house polyclonal mouse anti-Estrella antibodies
and secondary anti-mouse antibodies. All inclusions per cover-
slipwere quantified in duplicates in three different experiments.
Cell death quantification
Propidium iodide (5 μg ml−1) was added to infected or mock-
treated cells in a 96 well with RMPI 10% FCS without phenol
red. The fluorescencewasmeasuredwith a FLOUstar Omegami-
croplate reader (BMG Labtech, Offenburg, Germany). Lactate de-
hydrogenase (LDH) releasewasmeasuredwith the CytoTox-ONE
Homogeneous Membrane Integrity Assay (Promega) according
to manufacturer’s instructions. Changes in PI or LDH release
were tested with an unpaired non-parametric Mann-Whitney
test compared to mock-infected cells using GraphPad Prism ver-
sion 6.0 for Windows.
Antibody staining
Coverslips were blocked in blocking solution (0.3% Triton X-100
and 5% FCS in PBS) for 1 h at room temperature. For early endo-
somes (EEA1), late endosomes (LAMP-1), Golgi (RCAS1) and ER
(PDI) staining, the organelle localization kit (Cell Signaling Tech-
nology Inc., Beverly, USA) was used according to manufacturer’s
instructions with overnight incubation at 4◦Cwith a primary an-
tibody. After organelle staining, coverslips were washed three
times in PBS and incubated with in-house mouse polyclonal
antibodies against W. chondrophila (1:1000) or E. lausannensis
(1:1000) for 1 h at room temperature. Prior to incubation with
4′,6-diamidino-2-phenylindole (DAPI) (Life Technologies, Pais-
ley, Scotland) and secondary antibodies Alexa Fluor 488 goat
anti-mouse (1:1000) and Alexa Fluor 594 donkey anti-rabbit
(1:1000) (Molecular Probes Leiden, Netherlands) for 1 h at room
temperature, coverslips were washed three times in PBS. Fi-
nally, coverslips were washed three times in PBS and mounted
with MOEWIOL (Sigma-Aldrich, Buchs, Switzerland) on glass
slides.
For tubulin (Abcam Inc., Cambridge, UK) staining, the same
procedurewas used except that the primary antibody (1:200)was
incubated with the polyclonal anti-Waddlia or anti-Estrella for
1 h at room temperature. Actin filaments were directly stained
with Phalloidin CF594 (Biotium, Hayward, USA) together with
the polyclonal anti-Waddlia or anti-Estrella antibody at room
temperature for 1 h. All subsequent steps with secondary an-
tibodies were performed as described above. For mitochondrial
staining, cells were incubated with 250 nM of MitoTracker Red
CMXRos (Life Technologies) 30 min prior to fixation with ace-
tone. After 1 h blocking in triton-free blocking solution, cov-
erslips were incubated as described above for bacterial pri-
mary and secondary antibodies with anti-Waddlia or anti-Estrella
antibodies.
FM4-64 staining
FM4-64 staining protocols were adapted from Vieria et al. (2003)
for staining of infected cells. The cells were first infected and
then exposed to 5 μg FM4-64 (Life Technologies) for differ-
ent incubation times to determine the fusion of inclusions
with nascent phagosomes. Cells were fixed with 4% PFA and
extracellular bacteria were marked with anti-Estrella for 1 h.
Internal bacteria were marked with Hoechst without permeabi-
lization (Sigma-Aldrich). For detection of fusion with late endo-
somes or lysosomes, the cells were incubated with FM4–64 for
1 h and then pulsed for 3 h prior to infection. Cells were fixed
and marked as described beforehand.
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Infection and fixation
Differentiated macrophages grown on glass coverslips were in-
fected with E. lausannensis or W. chondrophila by spinoculation.
Cells were centrifuged for 15min at 1790 g and further incubated
15 min at 37◦C, 5% CO2, in order to allow bacterial internaliza-
tion. Cells were washed to eliminate all non-internalized bacte-
ria and freshmediumwas added. At different points in time post
infection (p.i.), cells were fixed with protocols adapted to each
antibody staining. For actin and tubulin staining, cells were fixed
in −20◦C methanol for 10 min. For MitoTracker Red CMXRos,
cells were incubated during 10 min in −20◦C acetone. For LAMP-
1 (Cell Signaling Technology Inc.) staining, cells were fixed in a
1:1 acetone/methanol solution for 10 min at −20◦C. For all other
organelle markers, cells were fixed with 4% paraformaldehyde
at room temperature for 15 min. For protein disulfide isomerase
(PDI) staining, an additionalmethanol permeabilization (10min,
−20◦C) was performed. All fixed samples were washed three
times with PBS.
Western blot
A T25 flask of confluent PLB-985 cells differentiated in
macrophages was infected with E. lausannensis either live or for-
mol inactivated with the previously describedmethod. At differ-
ent points in time, the supernatant was removed and the cells
were lysed in a 500μl RIPA buffer (Sigma-Aldrich). Proteins were
separated on a 12% pre-cast gel (Biorad Laboratories, Rheinach,
Switzerland) and transferred on a nitrocellulose membrane
(Membrane Solutions Inc., North Bend, USA). The membrane
was incubated over night with 1:1000 RCAS1 antibody (Cell Sig-
naling) and revealed by chemiluminescence with an anti-rabbit-
HRP antibody (Biorad). The membrane was stripped prior to
the control staining with GAPDH (Sigma-Aldrich). The antibody
was incubated overnight at a 1:250 dilution and revealed with
anti-mouse-HRP (Biorad) by chemiluminescence. Band intensity
was quantified with ImageJ (Rasband 1997–2014). Significance of
band intensity changes was assessed using an unpaired non-
parametric Mann-Whitney test.
Microtubules and actin disruption
A total of 20 μM of nocodazole (Sigma-Aldrich) and 10 μM cy-
tochalasin D (Sigma-Aldrich) were used to disrupt the cytoskele-
ton of infected macrophages. The drugs were added at different
points in time p.i. and the cells were fixedwithmethanol 12 h p.i.
The fixed coverslips were blocked and the bacteria were stained
with mouse anti-Estrella antibody and secondary Alexa488 anti-
mouse antibody as described above. The mounted coverslips
were analyzed with an automated Axiovision (Zeiss, Feldbach,
Switzerland). Four images of eight by eight tiles with a 20% over-
lapwere takenwith a 400×magnification. Images were acquired
in the FITC and DAPI channels. The acquired images were then
further processed with ImageJ to split the channels, define the
cell outline and the size of the inclusions (area). The inclusions
were divided into large, medium and small according to the sur-
face covered by the inclusion and normalized by the number of
infected cells. The number of inclusions determinedwith ImageJ
was normalized to 100 infected cells. Significance was tested
with an unpaired non-parametric Mann-Whitney test compared
to 0.1% DMSO-treated cells. GraphPad Prism version 6.0 forWin-
dows (GraphPad Software, La Jolla, CA, USA) was used for statis-
tical analysis.
Lysosome and ER-Golgi traffic disruption
To disrupt lysosomal acidification, the drug bafilomycin A (100
nM) was added to infected cells or mock-infected cells (0.1%
DMSO) for 12 h or 4 h p.i. For the disruption of the ER-Golgi
trafficking, the drug brefeldin A (1 μg ml−1) was used for the
same period of time. Cells were then fixed with 4% PFA and bac-
teria were stained with in-house polyclonal anti-E. lausannensis
antibodies for 1 h at room temperature. Secondary Alexa Fluor
488 goat anti-rabbit and DAPI were added for 1 h at room tem-
perature. Coverslips mounted in MOEWIOL were imaged with
a scanning Axiovision microscope. The tiled images were an-
alyzed with ImageJ to determine the amount of cells present
(DAPI staining) and the number of inclusions. Inclusions were
separated according to size (area) and normalized according to
the number of cells present on the slide.
Confocal microscopy and colocalization analysis
Images were acquired with a confocal microscope Zeiss LSM510
Meta or Zeiss LSM710 and analyzed with Zen 2009 Light edi-
tion software. For Golgi fragmentation, cells were analyzed with
an epifluorescentmicroscope (Leitz Diaplan, Leica, Switzerland).
Colocalization of all bacteria containing vacuoles and organelles
was assessed on 100 infected cells in three independent experi-
ments. Statistical analyses of the acquired data were performed
with GraphPad Prism version 6.0.
RESULTS
Estrella lausannensis replicates within macrophages
PLB-985 monocytes were differentiated into macrophage-like
adherent cells by adding 50 nM PMA for 48 h. The macrophages
were infected with E. lausannensiswith a bacterial load of two to
three bacteria per cell and an infection rate above 50%. Estrella
lausannensis readily differentiated into RBs 4 h p.i. The bacteria
started to replicate shortly after, and at 12 h p.i. large inclusions
were visible (Fig. 1a). At 16 h p.i., some of the bacteria were al-
ready redifferentiating into EBs. The growthwasmore than 1 log
(24-fold increase) in 24 h (Fig. 1b). Waddlia chondrophila, another
member of the Chlamydiales order, previously shown to multiply
in macrophages (Goy, Croxatto and Greub 2008), was used as a
control and replicated as well in this cell line (Fig. 1a). Within
the same time frame,W. chondrophila replication was about 1 log
higher than E. lausannensis at the same infection rate and bacte-
rial load (Fig. 1b). To determine the infectivity of the newly pro-
duced E. lausannensis, the infected cells were collected at 24 h
and used to re-infect Vero cells. We observed 20 times more in-
clusion forming units (IFU) with E. lausannensis derived from in-
fected macrophages collected at 24 h p.i. (12 ± 5.3 104 IFU) com-
pared to those collected at 0 h p.i. (6 ± 3.2 103 IFU).
At 4 and 6 h p.i., a significant fraction of E. lausannensis in-
fected cells showed a fragmented nucleus. This was not ob-
served in non-infected cells or in cells infected with W. chon-
drophila (Fig. 2a and b). To confirm the cytopathic effect of E. lau-
sannensis, we determined the amount of propidium iodide (PI)
that was taken up by infected cells (Fig. 2c). The proportion of PI
positive cells was significantly higher in E. lausannensis infected
macrophages compared to cells infected with W. chondrophila or
formol-inactivated E. lausannensis. These data were further con-
firmed by measuring LDH release, another cytopathic marker.
Only cells infected with live E. lausannensis caused a significant
4 FEMS Pathogens and Disease, 2015, Vol. 73, No. 5
Figure 1. Growth of E. lausannensis in human macrophages. (a) Growth of E. lau-
sannensis and W. chondrophila occurs in the same time frame. Bacteria differen-
tiate into RBs about 6 h p.i. Replication initiates rapidly with large inclusions
already visible at 12 h p.i. At 24 h p.i., most inclusions are mature, containing
infectious EBs. Bacteria are stained with in-house polyclonal rabbit or mouse
antibodies (green). Cells are marked with Texas Red conjugated-concanavalin A
(red) and DAPI (blue). Scale bar 10 μm. Pictures were taken at 1000× magnifica-
tion. (b) Bacterial growth was confirmed by specific qPCR. Data are the means
+/− SEM of at least three independent experiments performed in duplicates.
release of LDH (Fig. 2d). Infections with W. chondrophila or with
formol-inactivated bacteria did not cause cell death.
Estrella lausannensis escapes endosomal compartments
Estrella lausannensis-containing inclusions did not accumulate
the early endosomal marker EEA1 as seen for W. chondrophila-
containing vacuoles (Fig. 3a). The percentage of EEA1 positive E.
lausannensis bacteria-containing vacuoles (BCV) rose from 5 to
11% in the first 30 min p.i. and subsequently dropped again at
1 h p.i. Conversely, as previously described (Croxatto and Greub
2010), up to 30% of W. chondrophila BCV showed an EEA1 stain-
ing 15 min p.i., but it was then rapidly lost. We could not an-
alyze the trafficking of inactivated E. lausannensis, since these
bacteria were rapidly recycled back outside the macrophages or
degraded.
Even though the E. lausannensis BCV did not strongly accu-
mulate EEA1, we investigated if it still might acquire lysosomal
markers later in the infection. We did not observe any increase
in LAMP1 staining up to 6 h p.i., when the bacteria were already
differentiated into RBs. Only about 10% of E. lausannensis BCVs
showed a LAMP1 staining and the percentage remained stable
throughout time (Fig. 3b). To determine if the E. lausannensis BCV
was completely dissociated from the endosomal network, we
used the solvochromic FM4-64 compound in live cells. If E. lau-
sannensis BCV can still fuse with endosomal compartments, it
will acquire FM4-64 that enters the cells through the endosomal
pathway upon integration into the plasma membrane (Vieira
et al. 2003). Since FM4-64 can also integrate into the bacterial
membrane, staining was performed without permeabilization
in order to distinguish between the extra- and the intracellu-
lar bacteria. We observed a strong accumulation of FM4-64 in
the BCV. The majority of inclusions displayed a FM4-64 posi-
tive staining for up to 1 h p.i. (Fig. 3c). Even though the EEA1
staining started to decrease already after 30 min, E. lausannen-
sis BCV was still interacting with the endosomal network for a
longer period, since the FM4-64 stainingwas still strong at 1 h p.i.
To determine if E. lausannensis BCV could fuse with preexisting
lysosomes instead of maturating into a lysosome, we performed
a pulse and chase with FM4-64. The cells were incubated with
FM4-64 for 1 h and then chased for 3 h prior to infection. About
half of the inclusions that were fixed shortly after infection were
FM4-64 positive. The amount dropped rapidly over the next hour
(Fig. 3d).
Estrella lausannensis infected cells exhibit Golgi
fragmentation
Once we determined that E. lausannensis escapes the endosomal
route early on, we analyzed the interaction of the BCV with sev-
eral host organelles to define the nutriment source of this ob-
ligate intracellular bacteria. For E. lausannensis, we observed a
significant Golgi fragmentation at 4 h p.i. (Fig. 4a). However, the
fragmented Golgi did not accumulate around the BCV, contrar-
ily to what is known for Chlamydiaceae (Ying et al. 2008). Inter-
estingly, we also observed a Golgi degradation in macrophages
infected with W. chondrophila, although not to the same extent
(Fig. 4a). Here as well the BCV did not accumulate Golgi frag-
ments. Further the fate of RCAS1, a golgic protein, was followed
by Western blot (Fig. S1a, Supporting Information). There was
a degradation observable in E. lausannensis infected cells, but it
was not significant compared to mock-infected cells (Fig. S1b,
Supporting Information).
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Figure 2. Cytopathic effect of E. lausannensis (E. laus.). (a) Infected cells showed fragmented (white arrow) or condensed nuclei 8 h p.i., prior to bacterial replication. Scale
bar 10 μm. Pictures were taken at 1000× magnification. (b) Estrella lausannensis causes a significant increase of cells with fragmented nuclei at 6 h p.i. compared to W.
chondrophila and uninfected cells. The percentage of infected cells with fragmented nuclei was quantified in three independent experiments for 100 infected cells each
with SEM. (c) Quantification of the cytopathic effect was performed with the impermeable nucleic intercalating agent PI. Estrella lausannensis infected cells displayed
a significant accumulation of PI early p.i. compared to cells non-infected (mock) or infected with inactivated E. lausannensis in the first 16 hours. The total effect was
quantified by measuring the area under the curve (AUC). The data are the means +/− SEM of three independent experiments performed in triplicates. (d) Cytopathic
effect was further confirmed by monitoring LDH release. Data are the means +/− SEM of three independent experiments performed in triplicates. The cytopathic
effect was absent in cells infected with W. chondrophila or infected with formol-inactivated E. lausannensis. Significance was tested with an unpaired non-parametric
Mann-Whitney test compared to mock-infected cells (∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001, ∗∗∗∗P < 0.0001).
Estrella lausannensis is less associated with the ER
and mitochondria than W. chondrophila
We investigated the association of E. lausannensis BCV with the
ER, which is an important source of membranes and proteins,
by determining the colocalization of the inclusion with PDI, a
marker of the ER. For E. lausannensis BCV, we observed less than
20% of colocalization, compared to up to 60% forW. chondrophila
inclusions at 8 h p.i. (Fig. 4b). We also determined the colocal-
ization of the E. lausannensis inclusions with mitochondria that
represent a second source of energy and lipids. The recruitment
of mitochondria was much less pronounced in E. lausannensis
and occurred at later stages (Fig. 4c) than what is observed with
W. chondrophila. The recruitment is observed mainly at 6 h post
E. lausannensis infection, whereasW. chondrophila (used as a pos-
itive control) already recruits mitochondria 2 h p.i.
Disruption of cytoskeleton components delays
E. lausannensis replication
The interaction of the BCV with the different cellular or-
ganelles and compartments is regulated by the cytoskeleton.
The cytoskeleton either transports the inclusion to a given lo-
cation or transports the organelles to the inclusion. For the
Chlamydiales, several components of the cytoskeleton have been
shown to be relevant. Chlamydia trachomatis use microtubuli to
reach the microtubule organization center (MTOC) (Grieshaber,
Grieshaber and Hackstadt 2003). ForW. chondrophila, a single dis-
ruption of microtubuli or actin is not enough to prevent mi-
tochondria recruitment, the recruitment being abolished only
when both cytoskeletal elements are perturbed (Croxatto and
Greub 2010). Microtubuli can be disrupted by the drug nocoda-
zole and actin filaments by cytochalasin D. We analyzed the
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Figure 3. Early intracellular trafficking of E. lausannensis. (a) Infected cells were fixed at early time points to determine EEA-1 (red) localization on bacterial inclusions
(green).Waddlia chondrophila (Wch) significantly co-localizes with EEA-1, while E. lausannensis (Ela) does not. (b) LAMP-1 (red) staining was determined in E. lausannensis
(green) vacuoles. No accumulation of the lysosomal marker in the BCV was observed up to 6 h p.i (c) Acquisition of FM4-64 by E. lausannensis inclusions was followed
during 2 h p.i. Internalized bacteria (stained in blue with Hoechst) rapidly acquire a strong FM4-64 staining (red). Extracellular bacteria were stained with polyclonal
mouse anti-Estrella antibody. (d) A pulse and chase treatment of macrophages with FM4-64 allowed staining of late endosomes and lysosomes. Cells were subsequently
infected with E. lausannensis and fusion with previously formed lysosomes and late endosomes was quantified. About half of the internalized E. lausannensis fused with
these late endocytic compartments. The fusion event was transient as the amount of FM4-64 positive inclusions diminished rapidly. All experiments were performed
in triplicates on 100 infected cells. Results are presented with SEM. Images were acquired at a 630× magnification (scale bar 10 μm).
progression of E. lausannensis infection in presence of one or
both of these drugs by counting, at 12 h p.i., the number of in-
clusions of defined size (small, middle, large). Small inclusions
contain 5–10 replicating bacteria, medium size inclusions en-
compass 10–20 bacteria, and large inclusions between 20 and
50 bacteria. When cells were treated with nocodazole alone,
the number of inclusions was overall not altered (Fig. S2 e–
h, Supporting Information). Nevertheless, there were signifi-
cantlymore small inclusionswhen cells were treatedwith noco-
dazole between 0 and 2 h p.i. (P < 0.041) (Fig. S2e, Support-
ing Information) and there were significantly less medium size
inclusions upon treatment with nocodazole between 4 and 12 h
p.i. (P < 0.048) (Fig. S2f, Supporting Information). On the other
hand, early treatment with cytochalasin D significantly reduced
growth of E. lausannensis, even when cells were only exposed
to the drug during 2 h (Fig. S2d, Supporting Information). Later
exposures to this drug did not affect growth of E. lausannen-
sis. Combination of the two drugs blocked replication (Fig. 5a–
c) when applied early in infection and further blocked progres-
sion of replication when applied at later time points, since sig-
nificantly less large inclusions were observed (Fig. 5c). Inter-
estingly, when both filaments were disrupted, the growth of
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Figure 4. Interaction of E. lausannensis inclusion with host organelles. (a) Infec-
tion with E. lausannensis (green, Ela) causes Golgi (red) fragmentation without
recruitment of the Golgi fragments to the inclusion. Partial Golgi fragmentation
is also observed inmacrophages infectedwithW. chondrophila. (b) Co-localization
of ER marker PDI (red) with BCV was not observed for E. lausannensis (green) but
reached 60% for W. chondrophila at 8 h p.i. (c) Mitochondria (MitoTracker Red)
are recruited to a lesser extent by E. lausannensis inclusions (green) compared to
W. chondrophila. Nuclei are marked with DAPI (blue). All experiments were per-
formed in triplicates on 100 infected cells. Results are presented with SEM. Im-
ages were acquired at a 630× magnification. (scale bar 10 μm).
Figure 5. Role of the cytoskeleton in the replication of E. lausannensis. (a) The
number of small inclusions was reduced upon early or prolonged exposure to 10
μMnocodazole and 20 μM cytochlasin D. (b) The effect is evenmore pronounced
on medium-sized inclusions. (c) For large inclusions, even late treatment with
both drugs caused a reduction of the number of inclusions. (d) Total amount of
inclusions is significantly reduced in infected cells treated early or throughout
the infection with both drugs. Cells were fixed at 12 h p.i. and number of inclu-
sions was quantified. Inclusions were divided in three categories depending on
the area quantified (small, medium, large). Images of fixed cells were taken at
400× magnification with tiling. Data are the means +/− SEM of at least three
independent experiments performed in quadruplicates. Significance was tested
with an unpaired non-parametric Mann-Whitney test compared to 0.2% DMSO-
treated cells (∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001, ∗∗∗∗P < 0.0001).
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Figure 6. Disruption of ER-Golgi trafficking and lysosomal acidification. (a) Infected cells were treated either with the ER-Golgi trafficking disruptor brefeldin A or the
lysosomal acidification inhibitor bafilomycin A during 8 h starting 4 h p.i. None of the drugs affected the number of E. lausannensis small, medium or large inclusions.
(b) Treatment with either drug started immediately after internalization and prolonged during 12 hours did not affect the number of small, medium or large inclusions.
E. lausannensis was only reduced and not completely abolished
(Fig. 5d).
Lysosomal acidification and ER-Golgi trafficking
are not required for E. lausannensis replication
Although, most of the Chlamydiaceae escape the endosomal
route early, the lysosome is an important source of nutrients
and lysosomal acidification is crucial for chlamydial replication
(Ouellette et al. 2011). Since none of the organelles analyzed as-
sociatedwith the BCV,we disrupted lysosomal acidificationwith
bafilomycin A to determine its role as a nutriment source for E.
lausannensis. The replication of E. lausannensis was not affected
by the block of lysosomalmaturation, independently of the stage
of replication (Fig. 6a and b). Therewas no accumulation of small
inclusions, which reinforces the previous results that E. lausan-
nensis escapes the lysosomal degradation early.
Even if the disruption of the Golgi observed in our previous
experiments could be due to the cytopathic effect of E. lausan-
nensis, the ER-Golgi trafficking route could still play an impor-
tant role in nutrient acquisition, as was observed by Hackstadt,
Scidmore and Rockey (1995), for C. trachomatis. COPI-dependent
trafficking is important inW. chondrophila replication, despite an
intact Golgi in infected cells (Croxatto and Greub 2010). The ER-
Golgi trafficking was disrupted with brefeldin A just after infec-
tion, or after maturation into RBs. In both cases, the presence of
brefeldin A did not significantly affect E. lausannensis replication
(Fig. 6a and b).
DISCUSSION
In this work, we showed that E. lausannensis replicates in hu-
manmacrophages and escapes early the endocytic pathway. Es-
trella lausannensis induces a strong cytopathic effect early on dur-
ing infection preventing the completion of the replication cycle
in the majority of the infected cells. Absence of apoptosis in-
hibition has also been observed with members of the Parach-
lamydiaceae family (Sixt et al. 2012). Parachlamydia acanthamoe-
bae for example replicates only to a very limited extent within
macrophages and causes a rapid cell death (Greub, Mege and
Raoult 2003; Greub et al. 2005; Roger et al. 2010). When apoptosis
is blocked with a pan-caspase inhibitor, the bacterial growth is
greatly improved.
Disparities in the control of programmed cell death (PCD)
might explain the differences in the ability of Chlamydia-related
bacteria to grow, within macrophages. Waddlia chondrophila
is rapidly growing within human macrophages without early
cytopathic effect (Goy, Croxatto and Greub 2008), whereas
P. acanthamoebae causes a rapid cytopathic effect limiting its
replication (Greub, Mege and Raoult 2003). By comparison,
E. lausannensis displays an intermediary growth phenotype in
human macrophages with rapid growth limited by macrophage
PCD. To what extent the lack of PCD control by E. lausannensis is
involved in growth restriction remains to be determined. A re-
ducedmetabolic synthesis is an alternative hypothesis thatmay
explain this reduced growth (Kebbi-Beghdadi, Batista and Greub
2011), supported by genomic data that demonstrate a reduced
number of metabolic pathways in the genome of E. lausannensis
(Bertelli et al. 2015) compared to those encoded by the Waddlia
genome (Bertelli et al. 2010).
Estrella lausannensis is leaving the endocytic pathway early
upon infection. Escaping the endosomal network early is a strat-
egy developed by many intracellular bacteria to avoid degra-
dation. Mycobacterium tuberculosis prevents EEA1 accumulation
in the vacuole, therefore preventing further maturation into
phagolysosomes (Fratti et al. 2001). Only about 10% of the my-
cobacterial vacuoles are EEA1 positive compared to 30% with
latex beads at 10 min p.i. (Fratti et al. 2001). These results
are very similar to the ones obtained with E. lausannensis at
15 min p.i.
Interestingly, C. trachomatis trafficking varies depending on
the cell line used. In epithelial cells, the bacterial inclusions do
not recruit early endosomal markers such as EEA1 and Rab5
(Heinzen et al. 1996) and prevent the acquisition of lysosomal
and fluid phase markers. However, in macrophages, C. trachoma-
tis localizes rapidly in Rab7 positive compartments with in-
creased acidity. Moreover, C. trachomatis (serovar L2) has only a
very limited replication in macrophages (Sun et al. 2012). A sim-
ilar behavior is observed for P. acanthamoebae in macrophages,
with LAMP-1 accumulation and Lysotracker staining in the early
steps of infection (Greub et al. 2005). Estrella lausannensis does not
recruit early endosomal markers and additionally escapes the
fusion with lysosomes, since there is no accumulation of LAMP-
1, unlike what is observed for C. trachomatis (Sun et al. 2012) or P.
acanthamoebae (Greub et al. 2005). We therefore hypothesize that
the relatively reduced replication of E. lausannensis (as compared
toW. chondrophila) is not due to a targeting of the bacteria to lyso-
somal compartments (like C. trachomatis or P. acanthamoebae in
macrophages) but rather, as mentioned above, to a lack of con-
trol of PCD.
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The interaction of the maturating chlamydial inclusion with
several host organelles differs greatly between the different bac-
terial species, but depends also on the cell type used for infec-
tion. Golgi fragmentation has been observed for Chlamydiaceae
in epithelial cells with recruitment of Golgi fragments to the
chlamydial inclusion (Hackstadt, Scidmore and Rockey 1995).
However, macrophages infected with C. trachomatis (serovar L2)
did not display Golgi fragmentation nor interaction of the inclu-
sion with the Golgi (Sun et al. 2012). For E. lausannensis, the Golgi
was fragmented, but not recruited to the inclusion. Since Golgi
degradation occurs in the early steps of apoptosis (Mukherjee
et al. 2007), prior to nuclear fragmentation, we cannot exclude
that the fragmentation observed is due to the cytopathic effect
induced by E. lausannensis.
The role of ER in C. trachomatis infection of HeLa was recently
elucidated (Dumoux et al. 2012). Several ER markers accumulate
in patches within the inclusion and calreticulin marks the in-
clusion membrane. Since PDI, the ER marker used in our study
does not colocalize with the C. trachomatis inclusion, but rather
forms patches within the inclusion, more detailed studies with
Z-stacks of E. lausannensis would be useful to determine if the
same phenotype is observed for E. lausannensis. In contrast, for
W. chondrophila the PDI and calnexin staining showed a colocal-
ization with the inclusion (Croxatto and Greub 2010). It should
be noted that a recent publication by Dumoux et al. (2012) clearly
shows that depending on the ER protein used, the interaction
with the inclusion varies considerably. Other ER markers, like
calreticulin or calnexin could be used to further assess the role
of ER in E. lausannensis inclusion biogenesis.
The requirement for mitochondria at the inclusion varies
greatly between members of the Chlamydiales order. Inclusions
of C. psittaci, but not C. trachomatis or C. pneumoniae are sur-
rounded by mitochondria (Matsumoto et al. 1991). The same
observation was made for W. chondrophila (Croxatto and Greub
2010). Moreover, C. caviae replicationwas dependent on the pres-
ence of the Tim–Tom import complex found in mitochondria
(Derre et al. 2007). For E. lausannensis, mitochondrial recruitment
is not as pronounced as for W. chondrophila.
To recruit and interact with the host organelles, the bacterial
inclusion needs to either promote its ownmovement within the
cytoplasm or act on the cytoskeleton to attract the organelles of
interest. For C. trachomatis, the vacuole is known to migrate to
the MTOC near the nucleus (Grieshaber, Grieshaber and Hack-
stadt 2003). This movement is mediated by a modified dynein–
dynactin complex (Grieshaber, Grieshaber and Hackstadt 2003).
Since, E. lausannensis replication is not affected by the presence
of the microtubule-disrupting drug nocodazole, the reorganiza-
tion of the cell by E. lausannensis must occur through a differ-
ent mechanism. The sensitivity of E. lausannensis to cytocha-
lasin D treatment at early time points reveals the importance
of actin in E. lausannensis replication. So far, actin has been in-
volved in entry and exit of C. trachomatis (Carabeo et al. 2002;
Chin et al. 2012; Jiwani et al. 2012, 2013) and in mitochondria
recruitment of W. chondrophila (Croxatto and Greub 2010). For
E. lausannensis, the reduced replication following cytochalasin D
treatment is not due to a decreased entry, since the actin de-
polymerization was only induced after internalization. Interest-
ingly, the effect of cytochalasin D was not reversible, since re-
moval of the drug after 2 h did not allow complete recovery of
replication. Noteworthy, in contrast to what was observed for
W. chondrophila (Croxatto and Greub 2010), E. lausannensis repli-
cation was only decreased and could not be completely abol-
ished, even when cytochalasin D was combined with nocoda-
zole. Either E. lausannensis is able to use intermediary filaments
to recruit and transport the nutriments required for replication
or the bacteria can find everything within the replicative vac-
uole. Since, the replication of E. lausannensis is not very efficient,
a suboptimal growth might be possible even without an intact
cytoskeleton.
As the nature of the E. lausannensis inclusion could not be
established using several organelles and endosomal markers,
the source of nutriments for bacterial replication was further
investigated with additional inhibitors, such as bafilomycin A.
Chlamydia trachomatis and C. pneumoniae do not fuse with lyso-
somes, but are still dependent on intact lysosomal function for
replication (Ouellette et al. 2011). In E. lausannensis, the presence
of the lysosomalH+ ATPase pump inhibitor did not prevent repli-
cation, indicating a separate source of free amino acids. The
second candidate source was the ER-Golgi transport, which is
disrupted with brefeldin A. However, E. lausannensis was able to
replicate inmacrophages treated with brefeldin A. This is inma-
jor contrast to the majority of Chlamydiaceae for which this traf-
ficking pathway is required. Even for W. chondrophila, that does
not disrupt the Golgi, this pathway is required for successful
replication (Croxatto and Greub 2010). The source of lipids and
amino acids for the E. lausannensis inclusion remains to be estab-
lished and appears to rely on cellular pathways and components
that differ substantially from those used by other Chlamydiales.
In conclusion, the inability of E. lausannensis to control PCD in
infected macrophages and the limited growth within suggest
a lack of adaptation of this strict intracellular bacteria to the
macrophage.
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